You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD137

Showing 1 - 25 of 815
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced/Metastatic Solid Tumors Trial in Kurralta Park, Clayton (ADG206)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Kurralta Park, South Australia, Australia
  • +1 more
Nov 9, 2022

Advanced/Metastatic Solid Tumors Trial in Australia, United States (ADG116, ADG106, anti PD1 drug)

Recruiting
  • Advanced/Metastatic Solid Tumors
  • San Antonio, Texas
  • +3 more
Jan 26, 2022

Cancer Trial in Houston (LVGN7409)

Recruiting
  • Cancer
  • LVGN7409
  • Houston, Texas
    MD Anderson Cancer Center
Apr 4, 2022

Malignant Tumors of Ill-defined Secondary and Unspecified Sites, Malignant Tumors of Lip Oral Cavity and Pharynx, Oropharyngeal

Terminated
Has Results
  • Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 22, 2022

Cancer Trial in Beijing, Shanghai (LVGN6051, Pembrolizumab)

Recruiting
  • Cancer
  • Beijing, China
  • +1 more
Nov 24, 2021

Solid Tumor, Colorectal Tumors, NSCLC Trial in Korea, Republic of, United States (EU101)

Recruiting
  • Solid Tumor
  • +2 more
  • Philadelphia, Pennsylvania
  • +4 more
Jul 12, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain (FS222)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Pamplona, Navarra, Spain
  • +5 more
Mar 29, 2022

Advanced Cancer, Metastatic Cancer Trial in Spain, United States (FS120)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • New Haven, Connecticut
  • +7 more
Aug 8, 2022

Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
  • +15 more
Jan 13, 2023

Advanced and/or Metastatic Solid Tumours Trial in Groningen (Radiolabelled CB307, CB307)

Recruiting
  • Advanced and/or Metastatic Solid Tumours
  • Groningen, Netherlands
    University Medical Center Groningen,
Apr 28, 2023

Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma Trial in Baltimore (Stereotactic Body

Recruiting
  • Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
  • Pancreatic Ductal Adenocarcinoma
  • Stereotactic Body Radiation (SBRT)
  • +3 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Jan 28, 2022

Tumor and Peripheral Blood to Evaluate Efficacy of Cancer

Recruiting
  • Lung Cancer
  • Esophageal Cancer
  • In vitro stimulation of Pbmc with tumor antigen nanoparticles
  • Suzhou, Jiangsu, China
    The first affiliated hospital of soochow university
Mar 16, 2023

Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer Trial (Radiation: Diffusing Alpha Radiation

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
  • (no location specified)
Dec 11, 2022

Cytomegalovirus Infections, HIV, Vaccine Trial in United States (CMV-MVA Triplex, Placebo)

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV-MVA Triplex
  • Placebo
  • Birmingham, Alabama
  • +11 more
Jun 20, 2022

Pancreatic Cancer Trial in Baltimore (Tislelizumab, SX-682)

Not yet recruiting
  • Pancreatic Cancer
  • Baltimore, Maryland
    Johns Hopkins SKCCC
Jan 23, 2023

Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma Trial (DaRT seeds insertion)

Not yet recruiting
  • Pancreatic Cancer
  • +2 more
  • DaRT seeds insertion
  • (no location specified)
Sep 5, 2023

T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

Recruiting
  • T-cell Acute Lymphoblastic Leukemia/Lymphoma
  • Senl-T7
  • Beijing, Hebei, China
    Hebei yanda Hospital
Nov 22, 2022

Prostate Cancer Trial in Baltimore (Enoblituzumab, Standard of Care)

Not yet recruiting
  • Prostate Cancer
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Aug 25, 2023

COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

Active, not recruiting
  • COL6A3 Positive
  • +3 more
  • Aldesleukin
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

Solid Tumor, Adult Trial in Shanghai (HOT-1030)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Shanghai, China
    Shanghai Huaota Biopharmaceutical Co., Ltd.
Sep 17, 2021

HER2-negative Breast Cancer, Advanced Solid Tumor Trial in Singapore (ADG106, Doxorubicin, Cyclophosphamide)

Recruiting
  • HER2-negative Breast Cancer
  • Advanced Solid Tumor
  • Singapore, Singapore
    National University Hospital
Jun 9, 2022

HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Bladder Cancer Trial in United States (PRS-343)

Completed
  • HER2-positive Breast Cancer
  • +3 more
  • Tucson, Arizona
  • +9 more
Jan 18, 2022

High Grade B-Cell Non-Hodgkin's Lymphoma, Intermediate Grade B-Cell Non-Hodgkin's Lymphoma, Recurrent B-Cell Non-Hodgkin

Not yet recruiting
  • High Grade B-Cell Non-Hodgkin's Lymphoma
  • +3 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Leukemia, T Cell Trial in Beijing (CD7 CART)

Recruiting
  • Leukemia, T Cell
  • CD7 CART
  • Beijing, Hebei, China
    He bei Yan da Lu dao pei Hospital
May 24, 2022